Literature DB >> 310703

Hazards of sulphinpyrazone.

D Mattingly, M Bradley, P J Selley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 310703      PMCID： PMC1609982          DOI： 10.1136/bmj.2.6154.1786-c

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  Possible interaction of sulfinpyrazone with coumarins.

Authors:  J W Davis; L E Johns
Journal:  N Engl J Med       Date:  1978-10-26       Impact factor: 91.245
  1 in total
  4 in total

Review 1.  Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone.

Authors:  A K Pedersen; P Jakobsen; J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

2.  Enhanced drug metabolism after sulfinpyrazone treatment in patients aged 50 to 60 years.

Authors:  E Walter; C Staiger; J de Vries; E Weber; W Bitzer; M Degott; K Jüngling
Journal:  Klin Wochenschr       Date:  1982-11-15

3.  Interaction of sulphinpyrazone with warfarin.

Authors:  J O Miners; T Foenander; S Wanwimolruk; A S Gallus; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 4.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.